Cargando…

Training in Safe Opioid Prescribing and Treatment of Opioid Use Disorder in Internal Medicine Residencies: a National Survey of Program Directors

BACKGROUND: Training future clinicians in safe opioid prescribing (SOP) and treatment of opioid use disorder (OUD) is critical to address the opioid epidemic. The Accreditation Council on Graduate Medical Education requires all programs to provide instruction and experience in pain management and wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Windish, Donna M., Catalanotti, Jillian S., Zaas, Aimee, Kisielewski, Michael, Moriarty, John P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562932/
https://www.ncbi.nlm.nih.gov/pubmed/34729698
http://dx.doi.org/10.1007/s11606-021-07102-y
_version_ 1784593333537996800
author Windish, Donna M.
Catalanotti, Jillian S.
Zaas, Aimee
Kisielewski, Michael
Moriarty, John P.
author_facet Windish, Donna M.
Catalanotti, Jillian S.
Zaas, Aimee
Kisielewski, Michael
Moriarty, John P.
author_sort Windish, Donna M.
collection PubMed
description BACKGROUND: Training future clinicians in safe opioid prescribing (SOP) and treatment of opioid use disorder (OUD) is critical to address the opioid epidemic. The Accreditation Council on Graduate Medical Education requires all programs to provide instruction and experience in pain management and will mandate addiction medicine clinical experiences for internal medicine trainees. OBJECTIVE: Assess residents’ training in SOP and treatment of OUD and identify training barriers. DESIGN: Cross-sectional nationally representative survey was emailed in 2019. PARTICIPANTS: Four hundred twenty-two Association of Program Directors in Internal Medicine members in US internal medicine residency programs. MAIN MEASURES: Program opportunities and challenges to developing or implementing training in SOP, treatment of OUD, and buprenorphine waiver training, and perceived curricular effectiveness. KEY RESULTS: The response rate was 69.4% (293/422). Most programs required didactics in SOP (94.2%) and treatment of OUD (71.7%). Few programs required clinical experiences including addiction medicine clinics (28/240, 11.7%), inpatient consult services (11/240, 4.6%), or offsite treatment rotations (8/240, 3.3%). Lack of trained faculty limited developing or implementing curricula (61.5%). Few respondents reported that their program was “very effective” in teaching SOP (80/285, 28.1%) or treatment of OUD (43/282, 15.3%). Some programs offered buprenorphine waiver training to residents (83/286, 29.0%) and faculty (94/286, 32.9%) with few mandating training (11.7% (28/240) and 5.4% (13/240) respectively). Only 60 of 19,466 (0.3%) residents completed buprenorphine waiver training. Primary care programs/tracks were more likely to offer waiver training to residents (odds ratio [OR], 3.07; 95% CI, 1.68–5.60; P < 0.001) and faculty (OR, 1.08; 95% CI, 1.01–3.22; P = 0.05). CONCLUSIONS: In this nationally representative survey, few internal medicine residency programs provided clinical training in SOP and treatment of OUD, and training was not viewed as very effective. Lack of effective training may have adverse implications for patients, clinicians, and society. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11606-021-07102-y.
format Online
Article
Text
id pubmed-8562932
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-85629322021-11-03 Training in Safe Opioid Prescribing and Treatment of Opioid Use Disorder in Internal Medicine Residencies: a National Survey of Program Directors Windish, Donna M. Catalanotti, Jillian S. Zaas, Aimee Kisielewski, Michael Moriarty, John P. J Gen Intern Med Original Research BACKGROUND: Training future clinicians in safe opioid prescribing (SOP) and treatment of opioid use disorder (OUD) is critical to address the opioid epidemic. The Accreditation Council on Graduate Medical Education requires all programs to provide instruction and experience in pain management and will mandate addiction medicine clinical experiences for internal medicine trainees. OBJECTIVE: Assess residents’ training in SOP and treatment of OUD and identify training barriers. DESIGN: Cross-sectional nationally representative survey was emailed in 2019. PARTICIPANTS: Four hundred twenty-two Association of Program Directors in Internal Medicine members in US internal medicine residency programs. MAIN MEASURES: Program opportunities and challenges to developing or implementing training in SOP, treatment of OUD, and buprenorphine waiver training, and perceived curricular effectiveness. KEY RESULTS: The response rate was 69.4% (293/422). Most programs required didactics in SOP (94.2%) and treatment of OUD (71.7%). Few programs required clinical experiences including addiction medicine clinics (28/240, 11.7%), inpatient consult services (11/240, 4.6%), or offsite treatment rotations (8/240, 3.3%). Lack of trained faculty limited developing or implementing curricula (61.5%). Few respondents reported that their program was “very effective” in teaching SOP (80/285, 28.1%) or treatment of OUD (43/282, 15.3%). Some programs offered buprenorphine waiver training to residents (83/286, 29.0%) and faculty (94/286, 32.9%) with few mandating training (11.7% (28/240) and 5.4% (13/240) respectively). Only 60 of 19,466 (0.3%) residents completed buprenorphine waiver training. Primary care programs/tracks were more likely to offer waiver training to residents (odds ratio [OR], 3.07; 95% CI, 1.68–5.60; P < 0.001) and faculty (OR, 1.08; 95% CI, 1.01–3.22; P = 0.05). CONCLUSIONS: In this nationally representative survey, few internal medicine residency programs provided clinical training in SOP and treatment of OUD, and training was not viewed as very effective. Lack of effective training may have adverse implications for patients, clinicians, and society. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11606-021-07102-y. Springer International Publishing 2021-11-02 2022-08 /pmc/articles/PMC8562932/ /pubmed/34729698 http://dx.doi.org/10.1007/s11606-021-07102-y Text en © Society of General Internal Medicine 2021
spellingShingle Original Research
Windish, Donna M.
Catalanotti, Jillian S.
Zaas, Aimee
Kisielewski, Michael
Moriarty, John P.
Training in Safe Opioid Prescribing and Treatment of Opioid Use Disorder in Internal Medicine Residencies: a National Survey of Program Directors
title Training in Safe Opioid Prescribing and Treatment of Opioid Use Disorder in Internal Medicine Residencies: a National Survey of Program Directors
title_full Training in Safe Opioid Prescribing and Treatment of Opioid Use Disorder in Internal Medicine Residencies: a National Survey of Program Directors
title_fullStr Training in Safe Opioid Prescribing and Treatment of Opioid Use Disorder in Internal Medicine Residencies: a National Survey of Program Directors
title_full_unstemmed Training in Safe Opioid Prescribing and Treatment of Opioid Use Disorder in Internal Medicine Residencies: a National Survey of Program Directors
title_short Training in Safe Opioid Prescribing and Treatment of Opioid Use Disorder in Internal Medicine Residencies: a National Survey of Program Directors
title_sort training in safe opioid prescribing and treatment of opioid use disorder in internal medicine residencies: a national survey of program directors
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562932/
https://www.ncbi.nlm.nih.gov/pubmed/34729698
http://dx.doi.org/10.1007/s11606-021-07102-y
work_keys_str_mv AT windishdonnam traininginsafeopioidprescribingandtreatmentofopioidusedisorderininternalmedicineresidenciesanationalsurveyofprogramdirectors
AT catalanottijillians traininginsafeopioidprescribingandtreatmentofopioidusedisorderininternalmedicineresidenciesanationalsurveyofprogramdirectors
AT zaasaimee traininginsafeopioidprescribingandtreatmentofopioidusedisorderininternalmedicineresidenciesanationalsurveyofprogramdirectors
AT kisielewskimichael traininginsafeopioidprescribingandtreatmentofopioidusedisorderininternalmedicineresidenciesanationalsurveyofprogramdirectors
AT moriartyjohnp traininginsafeopioidprescribingandtreatmentofopioidusedisorderininternalmedicineresidenciesanationalsurveyofprogramdirectors